RevPages
Pomalid 4mg
by MEDIXO CENTRE Pharmaceuticals
Pomalid 4mg contains the active substance pomalidomide.This medicine is related to thalidomide and belongs to a group of drugs that affect the immune system (the body's natural defense mechanisms).
Recommended Features
- multiple myeloma
- Kaposi sarcoma
- treatment
Review on Pomalid 4mg
Pomalidomide is a third-generation immunomodulator. Multiple clinical studies have shown that pomalidomide-containing combination regimens have good effects in the treatment of relapsed and refractory multiple myeloma and can improve patient prognosis. In 2013, the U.S. Food and Drug Administration (FDA) approved pomalidomide for the treatment of relapsed and refractory multiple myeloma, and in May 2020, it was approved for the treatment of AIDS-related Kaposi's sarcoma.Related to Pomalid 4mg
Related Articles
The Topic of Multiple Myeloma in Singapore
Multiple myeloma (MM) is a cancer caused by abnormal plasma cells which accumulated in the bone marrow to interfere normal blood cells’ production. Plasma cells produce antibodies to against disease a...Sponsor Ads
About MEDIXO CENTRE 
Pharmaceuticals
10 connections, 0 recommendations, 139 honor points.Joined APSense since, December 23rd, 2023, From New delhi, India.
Created on Apr 13th 2024 03:52. Viewed 33 times.
Comments
No comment, be the first to comment.
